In t(X;1)(p11;q21)-positive renal cell carcinomas expressing a PRCCTFE3 fusion protein this function may be abrogated through an impairment of the PRCC-MAD2B interaction and a concomitant failure to shuttle MAD2B to the nucleus [15]. Here, PRCC is linked to hereditary clear cell renal cell carcinoma.